| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2007-05-23 01:14:41 UTC |
|---|
| Update Date | 2024-05-19 04:24:16 UTC |
|---|
| HMDB ID | HMDB0006344 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Phenylacetylglutamine |
|---|
| Description | Phenylacetylglutamine is a product formed from the conjugation of phenylacetate and glutamine. Technically, it is the amino acid acetylation product of phenylacetate (or phenylbutyrate after beta-oxidation). Phenylacetylglutamine is a normal constituent of human urine, but other mammals such as the dog, cat, rat, monkey, sheep, and horse do not excrete this compound. Phenylacetyl-CoA and L-glutamine react to form phenylacetylglutamine and coenzyme A. The enzyme (glutamine N-acetyl transferase) that catalyzes this reaction has been purified from human liver mitochondria and shown to be a polypeptide species distinct from glycine-N-acyltransferase. Phenylacetylglutamine is a major nitrogenous metabolite that accumulates in uremia (PMID: 2791363 , 8972626 ). It has been shown that over 50% of urine phenylacetylglutamine may be derived from kidney conjugation of free plasma phenylacetic acid and/or from the kidney's preferential filtration of conjugated phenylacetic acid (PMID: 6420430 ). Phenylacetylglutamine is elevated by a factor of two or more in the urine of patients with diet-controlled PKU or phenylketonuria (PMID: 34441968 ). Phenylacetylglutamine is a microbial metabolite found in Christensenellaceae, Lachnospiraceae and Ruminococcaceae (PMID: 26241311 ). |
|---|
| Structure | NC(=O)CC[C@H](NC(=O)CC1=CC=CC=C1)C(O)=O InChI=1S/C13H16N2O4/c14-11(16)7-6-10(13(18)19)15-12(17)8-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H2,14,16)(H,15,17)(H,18,19)/t10-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| alpha-N-Phenylacetyl-L-glutamine | ChEBI | | Phenylacetyl-L-glutamine | ChEBI | | N2-(2-Phenylacetyl)-L-glutamine | Kegg | | a-N-Phenylacetyl-L-glutamine | Generator | | Α-N-phenylacetyl-L-glutamine | Generator | | Phenylacetylglutamine | ChEBI | | N(2)-(Phenylacetyl)-L-glutamine | HMDB | | N(2)-(2-Phenylacetyl)-L-glutamine | Generator, HMDB | | N-Phenylacetylglutamine | HMDB | | N2-(Phenylacetyl)-L-glutamine | HMDB | | α-N-Phenylacetylglutamine | HMDB | | alpha-N-Phenylacetylglutamine | Generator, HMDB |
|
|---|
| Chemical Formula | C13H16N2O4 |
|---|
| Average Molecular Weight | 264.2771 |
|---|
| Monoisotopic Molecular Weight | 264.11100701 |
|---|
| IUPAC Name | (2S)-4-carbamoyl-2-(2-phenylacetamido)butanoic acid |
|---|
| Traditional Name | phenylacetylglutamine |
|---|
| CAS Registry Number | 28047-15-6 |
|---|
| SMILES | NC(=O)CC[C@H](NC(=O)CC1=CC=CC=C1)C(O)=O |
|---|
| InChI Identifier | InChI=1S/C13H16N2O4/c14-11(16)7-6-10(13(18)19)15-12(17)8-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H2,14,16)(H,15,17)(H,18,19)/t10-/m0/s1 |
|---|
| InChI Key | JFLIEFSWGNOPJJ-JTQLQIEISA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as n-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | N-acyl-alpha amino acids |
|---|
| Alternative Parents | |
|---|
| Substituents | - N-acyl-alpha-amino acid
- Monocyclic benzene moiety
- Benzenoid
- Carboximidic acid
- Carboximidic acid derivative
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Organic nitrogen compound
- Organonitrogen compound
- Organooxygen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Carbonyl group
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 3.48 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.9998 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 5.06 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 176.6 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1191.2 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 229.8 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 115.9 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 167.5 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 84.3 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 271.5 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 326.1 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 618.5 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 739.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 311.7 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 932.9 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 214.5 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 225.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 369.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 332.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 144.5 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Phenylacetylglutamine,1TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@H](CCC(N)=O)NC(=O)CC1=CC=CC=C1 | 2440.1 | Semi standard non polar | 33892256 | | Phenylacetylglutamine,1TMS,isomer #2 | C[Si](C)(C)NC(=O)CC[C@H](NC(=O)CC1=CC=CC=C1)C(=O)O | 2493.7 | Semi standard non polar | 33892256 | | Phenylacetylglutamine,1TMS,isomer #3 | C[Si](C)(C)N(C(=O)CC1=CC=CC=C1)[C@@H](CCC(N)=O)C(=O)O | 2433.2 | Semi standard non polar | 33892256 | | Phenylacetylglutamine,2TMS,isomer #1 | C[Si](C)(C)NC(=O)CC[C@H](NC(=O)CC1=CC=CC=C1)C(=O)O[Si](C)(C)C | 2492.5 | Semi standard non polar | 33892256 | | Phenylacetylglutamine,2TMS,isomer #1 | C[Si](C)(C)NC(=O)CC[C@H](NC(=O)CC1=CC=CC=C1)C(=O)O[Si](C)(C)C | 2421.2 | Standard non polar | 33892256 | | Phenylacetylglutamine,2TMS,isomer #1 | C[Si](C)(C)NC(=O)CC[C@H](NC(=O)CC1=CC=CC=C1)C(=O)O[Si](C)(C)C | 3115.4 | Standard polar | 33892256 | | Phenylacetylglutamine,2TMS,isomer #2 | C[Si](C)(C)OC(=O)[C@H](CCC(N)=O)N(C(=O)CC1=CC=CC=C1)[Si](C)(C)C | 2400.3 | Semi standard non polar | 33892256 | | Phenylacetylglutamine,2TMS,isomer #2 | C[Si](C)(C)OC(=O)[C@H](CCC(N)=O)N(C(=O)CC1=CC=CC=C1)[Si](C)(C)C | 2339.5 | Standard non polar | 33892256 | | Phenylacetylglutamine,2TMS,isomer #2 | C[Si](C)(C)OC(=O)[C@H](CCC(N)=O)N(C(=O)CC1=CC=CC=C1)[Si](C)(C)C | 3491.6 | Standard polar | 33892256 | | Phenylacetylglutamine,2TMS,isomer #3 | C[Si](C)(C)N(C(=O)CC[C@H](NC(=O)CC1=CC=CC=C1)C(=O)O)[Si](C)(C)C | 2576.1 | Semi standard non polar | 33892256 | | Phenylacetylglutamine,2TMS,isomer #3 | C[Si](C)(C)N(C(=O)CC[C@H](NC(=O)CC1=CC=CC=C1)C(=O)O)[Si](C)(C)C | 2494.1 | Standard non polar | 33892256 | | Phenylacetylglutamine,2TMS,isomer #3 | C[Si](C)(C)N(C(=O)CC[C@H](NC(=O)CC1=CC=CC=C1)C(=O)O)[Si](C)(C)C | 3323.4 | Standard polar | 33892256 | | Phenylacetylglutamine,2TMS,isomer #4 | C[Si](C)(C)NC(=O)CC[C@@H](C(=O)O)N(C(=O)CC1=CC=CC=C1)[Si](C)(C)C | 2445.2 | Semi standard non polar | 33892256 | | Phenylacetylglutamine,2TMS,isomer #4 | C[Si](C)(C)NC(=O)CC[C@@H](C(=O)O)N(C(=O)CC1=CC=CC=C1)[Si](C)(C)C | 2472.1 | Standard non polar | 33892256 | | Phenylacetylglutamine,2TMS,isomer #4 | C[Si](C)(C)NC(=O)CC[C@@H](C(=O)O)N(C(=O)CC1=CC=CC=C1)[Si](C)(C)C | 3229.1 | Standard polar | 33892256 | | Phenylacetylglutamine,3TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@H](CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)NC(=O)CC1=CC=CC=C1 | 2533.2 | Semi standard non polar | 33892256 | | Phenylacetylglutamine,3TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@H](CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)NC(=O)CC1=CC=CC=C1 | 2507.9 | Standard non polar | 33892256 | | Phenylacetylglutamine,3TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@H](CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)NC(=O)CC1=CC=CC=C1 | 2939.7 | Standard polar | 33892256 | | Phenylacetylglutamine,3TMS,isomer #2 | C[Si](C)(C)NC(=O)CC[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)CC1=CC=CC=C1)[Si](C)(C)C | 2433.2 | Semi standard non polar | 33892256 | | Phenylacetylglutamine,3TMS,isomer #2 | C[Si](C)(C)NC(=O)CC[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)CC1=CC=CC=C1)[Si](C)(C)C | 2469.8 | Standard non polar | 33892256 | | Phenylacetylglutamine,3TMS,isomer #2 | C[Si](C)(C)NC(=O)CC[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)CC1=CC=CC=C1)[Si](C)(C)C | 2915.7 | Standard polar | 33892256 | | Phenylacetylglutamine,3TMS,isomer #3 | C[Si](C)(C)N(C(=O)CC1=CC=CC=C1)[C@@H](CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O | 2502.9 | Semi standard non polar | 33892256 | | Phenylacetylglutamine,3TMS,isomer #3 | C[Si](C)(C)N(C(=O)CC1=CC=CC=C1)[C@@H](CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O | 2570.8 | Standard non polar | 33892256 | | Phenylacetylglutamine,3TMS,isomer #3 | C[Si](C)(C)N(C(=O)CC1=CC=CC=C1)[C@@H](CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O | 3062.2 | Standard polar | 33892256 | | Phenylacetylglutamine,4TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@H](CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)N(C(=O)CC1=CC=CC=C1)[Si](C)(C)C | 2503.0 | Semi standard non polar | 33892256 | | Phenylacetylglutamine,4TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@H](CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)N(C(=O)CC1=CC=CC=C1)[Si](C)(C)C | 2563.3 | Standard non polar | 33892256 | | Phenylacetylglutamine,4TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@H](CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)N(C(=O)CC1=CC=CC=C1)[Si](C)(C)C | 2793.8 | Standard polar | 33892256 | | Phenylacetylglutamine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CCC(N)=O)NC(=O)CC1=CC=CC=C1 | 2693.1 | Semi standard non polar | 33892256 | | Phenylacetylglutamine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC(=O)CC[C@H](NC(=O)CC1=CC=CC=C1)C(=O)O | 2732.4 | Semi standard non polar | 33892256 | | Phenylacetylglutamine,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N(C(=O)CC1=CC=CC=C1)[C@@H](CCC(N)=O)C(=O)O | 2674.4 | Semi standard non polar | 33892256 | | Phenylacetylglutamine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=O)CC[C@H](NC(=O)CC1=CC=CC=C1)C(=O)O[Si](C)(C)C(C)(C)C | 2941.2 | Semi standard non polar | 33892256 | | Phenylacetylglutamine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=O)CC[C@H](NC(=O)CC1=CC=CC=C1)C(=O)O[Si](C)(C)C(C)(C)C | 2783.9 | Standard non polar | 33892256 | | Phenylacetylglutamine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=O)CC[C@H](NC(=O)CC1=CC=CC=C1)C(=O)O[Si](C)(C)C(C)(C)C | 3251.6 | Standard polar | 33892256 | | Phenylacetylglutamine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CCC(N)=O)N(C(=O)CC1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 2891.0 | Semi standard non polar | 33892256 | | Phenylacetylglutamine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CCC(N)=O)N(C(=O)CC1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 2759.6 | Standard non polar | 33892256 | | Phenylacetylglutamine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CCC(N)=O)N(C(=O)CC1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 3537.1 | Standard polar | 33892256 | | Phenylacetylglutamine,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N(C(=O)CC[C@H](NC(=O)CC1=CC=CC=C1)C(=O)O)[Si](C)(C)C(C)(C)C | 3037.9 | Semi standard non polar | 33892256 | | Phenylacetylglutamine,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N(C(=O)CC[C@H](NC(=O)CC1=CC=CC=C1)C(=O)O)[Si](C)(C)C(C)(C)C | 2850.1 | Standard non polar | 33892256 | | Phenylacetylglutamine,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N(C(=O)CC[C@H](NC(=O)CC1=CC=CC=C1)C(=O)O)[Si](C)(C)C(C)(C)C | 3351.3 | Standard polar | 33892256 | | Phenylacetylglutamine,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)NC(=O)CC[C@@H](C(=O)O)N(C(=O)CC1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 2924.7 | Semi standard non polar | 33892256 | | Phenylacetylglutamine,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)NC(=O)CC[C@@H](C(=O)O)N(C(=O)CC1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 2817.9 | Standard non polar | 33892256 | | Phenylacetylglutamine,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)NC(=O)CC[C@@H](C(=O)O)N(C(=O)CC1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 3315.1 | Standard polar | 33892256 | | Phenylacetylglutamine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)NC(=O)CC1=CC=CC=C1 | 3223.5 | Semi standard non polar | 33892256 | | Phenylacetylglutamine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)NC(=O)CC1=CC=CC=C1 | 3046.6 | Standard non polar | 33892256 | | Phenylacetylglutamine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)NC(=O)CC1=CC=CC=C1 | 3172.7 | Standard polar | 33892256 | | Phenylacetylglutamine,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC(=O)CC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CC1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 3100.3 | Semi standard non polar | 33892256 | | Phenylacetylglutamine,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC(=O)CC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CC1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 2996.9 | Standard non polar | 33892256 | | Phenylacetylglutamine,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC(=O)CC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)CC1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 3192.3 | Standard polar | 33892256 | | Phenylacetylglutamine,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N(C(=O)CC1=CC=CC=C1)[C@@H](CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O | 3205.5 | Semi standard non polar | 33892256 | | Phenylacetylglutamine,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N(C(=O)CC1=CC=CC=C1)[C@@H](CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O | 3078.9 | Standard non polar | 33892256 | | Phenylacetylglutamine,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N(C(=O)CC1=CC=CC=C1)[C@@H](CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O | 3252.1 | Standard polar | 33892256 | | Phenylacetylglutamine,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N(C(=O)CC1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 3361.4 | Semi standard non polar | 33892256 | | Phenylacetylglutamine,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N(C(=O)CC1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 3252.6 | Standard non polar | 33892256 | | Phenylacetylglutamine,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N(C(=O)CC1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 3122.3 | Standard polar | 33892256 |
|
|---|
| Spectra |
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Phenylacetylglutamine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-9520000000-5d0fcec2811fdda6e493 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Phenylacetylglutamine GC-MS (1 TMS) - 70eV, Positive | splash10-006x-9210000000-b1470e0601bcb76fcdda | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Phenylacetylglutamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglutamine Linear Ion Trap , negative-QTOF | splash10-0002-0900000000-16da6849ac342b179bb0 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglutamine Linear Ion Trap , positive-QTOF | splash10-00di-0190000000-0e5d477fb2aa8bfecaba | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglutamine Linear Ion Trap , positive-QTOF | splash10-001l-0090000000-b74aefa0573c8e2d497c | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglutamine 30V, Positive-QTOF | splash10-001i-9300000000-309b6dbe599b4262ff80 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglutamine 10V, Positive-QTOF | splash10-0019-1790000000-34a22833325f47aff746 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglutamine 35V, Positive-QTOF | splash10-001i-3900000000-2056d9abb5c0fdd85256 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglutamine 0V, Positive-QTOF | splash10-014r-0090000000-9a963271774da671d529 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglutamine 10V, Positive-QTOF | splash10-001r-2950000000-506c649376dd55c452c1 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglutamine 0V, Positive-QTOF | splash10-014i-0090000000-3cd0e6901a93d015f159 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglutamine 30V, Positive-QTOF | splash10-001l-9200000000-25c13edfa9d657619b43 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglutamine 10V, Positive-QTOF | splash10-001i-1910000000-7f99e9784ad6de2851d8 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglutamine 20V, Positive-QTOF | splash10-001i-5900000000-a9229c68d62fec012834 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglutamine 40V, Positive-QTOF | splash10-001l-9000000000-0f312f25ec486fde9a50 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglutamine 20V, Negative-QTOF | splash10-002b-0900000000-fc88effe954753003aa1 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglutamine 30V, Negative-QTOF | splash10-004i-3900000000-cd91c7242291d95e088e | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglutamine 10V, Negative-QTOF | splash10-0002-0910000000-c889b0e15c63f54c93e1 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglutamine 35V, Negative-QTOF | splash10-0002-0900000000-be097e5cfb29710afc22 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglutamine 40V, Negative-QTOF | splash10-054o-9500000000-09820d1b2dd8e5f5d551 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylacetylglutamine 10V, Negative-QTOF | splash10-0002-0910000000-bd099f1990927d0cc710 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenylacetylglutamine 10V, Positive-QTOF | splash10-00kb-1590000000-43b5b1154ff8c459a8e4 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenylacetylglutamine 20V, Positive-QTOF | splash10-0002-5950000000-d9a6090fc4170f3cbec0 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenylacetylglutamine 40V, Positive-QTOF | splash10-0006-9300000000-74c33c21f286a44eb712 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenylacetylglutamine 10V, Negative-QTOF | splash10-03di-0290000000-c95723e9e5991b3a938f | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenylacetylglutamine 20V, Negative-QTOF | splash10-02td-5980000000-c54142cded19fc0b1975 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenylacetylglutamine 40V, Negative-QTOF | splash10-0006-9200000000-744617f4104fc833e5d6 | 2016-08-03 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
|
|---|
| Biological Properties |
|---|
| Cellular Locations | |
|---|
| Biospecimen Locations | |
|---|
| Tissue Locations | |
|---|
| Pathways | |
|---|
| Normal Concentrations |
|---|
| |
| Blood | Detected and Quantified | 3.34 +/- 0.31 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | <17.803 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 71.0 +/- 6.0 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 47.03 (3.84 - 85.51) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | | Urine | Detected and Quantified | 34.0 (4.5-70.0) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 13.731 +/- 2.994 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Normal | | details | | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 22.67 (17.32-33.98) umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details |
|
|---|
| Abnormal Concentrations |
|---|
| |
| Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Hemodialysis patients with colons | | details | | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Hemodialysis patients without colons | | details | | Blood | Detected and Quantified | 201.894 +/- 169.318 uM | Adult (>18 years old) | Both | Uremia | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Hypertension (mild) | | details | | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Hypertension (mild) | | details | | Urine | Detected and Quantified | 27.595 +/- 24.094 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Eosinophilic esophagitis | | details |
|
|---|
| Associated Disorders and Diseases |
|---|
| Disease References | | Uremia |
|---|
- Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jorres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W: Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 2003 May;63(5):1934-43. doi: 10.1046/j.1523-1755.2003.00924.x. [PubMed:12675874 ]
| | Colorectal cancer |
|---|
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
| | Eosinophilic esophagitis |
|---|
- Slae, M., Huynh, H., Wishart, D.S. (2014). Analysis of 30 normal pediatric urine samples via NMR spectroscopy (unpublished work). NA.
|
|
|---|
| Associated OMIM IDs | - 114500 (Colorectal cancer)
- 610247 (Eosinophilic esophagitis)
|
|---|
| External Links |
|---|
| DrugBank ID | Not Available |
|---|
| Phenol Explorer Compound ID | Not Available |
|---|
| FooDB ID | FDB023896 |
|---|
| KNApSAcK ID | C00052383 |
|---|
| Chemspider ID | 83292 |
|---|
| KEGG Compound ID | C04148 |
|---|
| BioCyc ID | CPD-1097 |
|---|
| BiGG ID | 43248 |
|---|
| Wikipedia Link | Phenylacetylglutamine |
|---|
| METLIN ID | Not Available |
|---|
| PubChem Compound | 92258 |
|---|
| PDB ID | Not Available |
|---|
| ChEBI ID | 17884 |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | PHEACGLN |
|---|
| MarkerDB ID | MDB00000483 |
|---|
| Good Scents ID | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Suyama, Tadashi; Toyoda, Takeshi; Kanao, Seizo. N-Phenylacetyl amino acids and their homologs. I. N-Acylamino acids. Yakugaku Zasshi (1965), 85(4), 279-83. CODEN: YKKZAJ ISSN:0031-6903. CAN 63:39385 AN 1965:439385 |
|---|
| Material Safety Data Sheet (MSDS) | Not Available |
|---|
| General References | - Karoum F, Chuang LW, Mosnaim AD, Staub RA, Wyatt RJ: Plasma and cerebrospinal fluid concentration of phenylacetic acid in humans and monkeys. J Chromatogr Sci. 1983 Dec;21(12):546-50. [PubMed:6420430 ]
- Zimmerman L, Egestad B, Jornvall H, Bergstrom J: Identification and determination of phenylacetylglutamine, a major nitrogenous metabolite in plasma of uremic patients. Clin Nephrol. 1989 Sep;32(3):124-8. [PubMed:2791363 ]
- Shockcor JP, Unger SE, Wilson ID, Foxall PJ, Nicholson JK, Lindon JC: Combined HPLC, NMR spectroscopy, and ion-trap mass spectrometry with application to the detection and characterization of xenobiotic and endogenous metabolites in human urine. Anal Chem. 1996 Dec 15;68(24):4431-5. [PubMed:8972626 ]
- Barrios C, Beaumont M, Pallister T, Villar J, Goodrich JK, Clark A, Pascual J, Ley RE, Spector TD, Bell JT, Menni C: Gut-Microbiota-Metabolite Axis in Early Renal Function Decline. PLoS One. 2015 Aug 4;10(8):e0134311. doi: 10.1371/journal.pone.0134311. eCollection 2015. [PubMed:26241311 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
- Andrade F, Cano A, Unceta Suarez M, Arza A, Vinuesa A, Ceberio L, Lopez-Osle N, de Frutos G, Lopez-Oceja R, Aznal E, Gonzalez-Lamuno D, de Las Heras J: Urine Phenylacetylglutamine Determination in Patients with Hyperphenylalaninemia. J Clin Med. 2021 Aug 19;10(16):3674. doi: 10.3390/jcm10163674. [PubMed:34441968 ]
|
|---|